Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

WHO Approves HPV Vaccine Cervarix For Use In Developing Countries
The World Health Organization has approved GlaxoSmithKline"s human papillomavirus vaccine Cervarix, thus enabling United Nations agencies and partners to officially purchase millions of doses for use in low-income nations, the AP/San Diego Union-Tribune reports (AP/San Diego Union-Tribune, 7/9). Cervarix is highly effective at preventing HPV types 16 and 18, which cause about 70% of cervical cancer cases (GSK release, 7/9). According to the AP/Union-Tribune, more than 80% of the estimated 280,000 cervical cancer deaths annually occur in developing countries.Cervarix has not been approved for use in the U.S. and Japan, but it is available in 97 other countries. FDA is expected to decide in the next few months whether to approve Cervarix for use in the U.S. (AP/San Diego Union-Tribune, 7/9). The agency in 2006 approved Merck"s HPV vaccine Gardasil for girls and women ages nine to 26. Centers for Disease Control and Prevention guidelines recommend routine three-dose vaccination for girls ages 11 and 12 and for girls and women ages 13 to 26 who have not yet been vaccinated (CDC fact sheet, June 2008).The three-shot regimen typically costs about $360. It is unclear if GSK will provide Cervarix at a lower cost to U.N. agencies purchasing it for developing countries (AP/San Diego Union-Tribune, 7/9). GSK said that it is "eager to work with our long-term partner GAVI as well as other private [non-governmental organizations] or governments of developing countries to identify financing mechanisms for the vaccine" (Stovall, Dow Jones, 7/9). The global health association GAVI is a major buyer of vaccines for the developing world. In 2008, GAVI prioritized the purchase of HPV vaccines for the world"s 73 poorest nations. The organization includes U.N. agencies, the World Bank and the Bill and Melinda Gates Foundation (AP/San Diego Union-Tribune, 7/9).

HCV Protease Inhibitor Telaprevir Improves Response, Halves Treatment Time For Hepatitis C Patients
For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.
News of the day
Indian Authorities Asked To Stop Licensing Artemisinin-Only Malaria Drugs
The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports. To prevent drug resistance, the WHO has advised against the use of drugs that only contain artemisinin to treat malaria and recommends using artemsinin in combination with other drugs. "India"s drug advisory body, the drug consultative committee, had in December approved the phasing out of the [artemisinin only] drug[s] from the market," livemint.com writes.
Sexual Health

World Cup Campaign To Build Centers To Provide HIV/AIDS Education, Other Services To At-Risk African Youth

Authorities in South Africa have begun construction of one of the 20 planned Football for Hope centers in Africa -- part of a 2010 World Cup campaign called "20 Centers for 2010" aimed at reducing the prevalence of HIV/AIDS, poverty and crime in local communities -- the AP/Google.com reports. The center under construction in South Africa"s Khayelitsha township will include a soccer field, community center and after-school programs that will focus on sex education and HIV/AIDS education. The International Federation of Football Association, or FIFA, in alliance with Streetfootballworld, a network of development groups, is providing the campaign with $10 million in funding. Ghana, Kenya, Mali, Namibia, Rwanda and other African countries will be home to the remaining 19 centers.According to FIFA President Joseph Blatter, the campaign "emphasizes the power of football far beyond the boundaries of the pitch." He added that the centers will "provide a platform for communities to address social issues such as children"s rights, education, health, HIV/AIDS prevention and will leave a legacy for Africa that will last long after the final whistle of the 2010 FIFA World Cup has been blown." Helen Zille, premier of the Western Cape Province, said construction of the center in the township "shows what we can do when we focus on getting things right rather than concentrating on what"s wrong," adding that she hopes the center is successful with its HIV/AIDS education efforts. The center will be run by Grassroots Soccer, an HIV/AIDS education organization that uses the sport to educate youth. Nocawe Tyali, a life-skills and football teacher who works with teenagers, said the new center will give young people an alternative to high-risk behaviors and enable the area to offer more youth football programs that include an HIV/AIDS prevention message (Nullis, AP/Google.com, 5/25). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009